Category: Merck – Schering Plough

Claritin Wins Bronze (Best Branded Integrated): OTC – Perspectives

2010 OTC National Advertising Award Winners Announced

Leading healthcare companies and brands were honored at the 2nd annual OTC National awards reception which showcased the best OTC marketing and advertising campaigns with Gold, Silver, and Bronze awards across eight categories. Brands among the winners include Vicks, Pepcid, Pepto Bismol, Triaminic, Durex.

“Delegates who attended the OTC National Conference determine the winners for Best Branded TV and Best Branded Print Campaign award,” announced Bob Ehrlich, CEO of DTC Perspectives, and OTC National Conference Chairman. “Independent expert judging panels will determine award winners for the other categories.”

“We congratulate all the winners of the OTC National Advertising Awards for their creative, effective campaigns” said Editor in Chief of OTC Perspectives Magazine Mark Tosh. OTC Perspectives Magazine will include coverage of the OTC National Conference and will profile each of the OTC National Advertising Award winners in an upcoming issue.

Posted via web from rahulsabnis’ posterous

Santarus Announces Launch of ZEGERID OTC by Schering-Plough Consumer HealthCare

ZEGERID OTC Now Available on Retail Store Shelves in the U.S.

April 1, 2010, 9:15 a.m. EDT

SAN DIEGO, Apr 01, 2010 (BUSINESS WIRE) — Santarus, Inc., a specialty biopharmaceutical company, today announced that Schering-Plough HealthCare Products, Inc., the consumer healthcare subsidiary of Merck & Co., Inc., has commenced promotion of ZEGERID OTC(TM) (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules) under its licensing agreement with Santarus for the over-the-counter (OTC) market in North America. The OTC heartburn market in the U.S. is estimated at approximately $1.8 billion based on data from market research firm Information Resources, Inc. and Santarus estimates.

Under the terms of the ZEGERID OTC license agreement, Santarus is entitled to a low double-digit royalty, subject to adjustment in certain circumstances, on net sales of any ZEGERID OTC products sold in North America. In turn, Santarus will be obligated to pay royalties to the University of Missouri on net sales of any such OTC products. Santarus also may be entitled to receive up to an additional $37.5 million in sales milestones.

ZEGERID OTC is the only OTC proton pump inhibitor (PPI) product with two active ingredients, omeprazole, a PPI, and sodium bicarbonate. The sodium bicarbonate acts as a buffer to raise the gastric pH and protect the omeprazole from acid degradation in the stomach and allows it to be absorbed. ZEGERID OTC is a 14-day course of treatment taken once daily as directed to treat frequent heartburn, defined as heartburn that occurs two or more days a week. For more information about ZEGERID OTC, visit www.ZegeridOTC.com. (more…)

Non-Drowsy CLARITIN(R) Partners with Kara DioGuardi, Judge on TV’s Hottest Show, to Collect Inspirational Stories from Allergy Sufferers Across America

Video contest gives allergy sufferers a chance to share their stories and star in online CLARITIN commercial and win $10,000

March 19, 2010: 08:00 AM ET

WHITEHOUSE STATION, N.J., March 19 /PRNewswire-FirstCall/ — Schering-Plough Consumer HealthCare, a subsidiary of Merck & Co.(NYSE: MRK), and the maker of non-drowsy CLARITIN allergy medicines, wants to learn what millions of American allergy sufferers are able to do when they aren’t hindered by bothersome symptoms. The brand is teaming up with long-time allergy sufferer Kara DioGuardi, judge on TV’s No. 1 hit series, to share her story and encourage others to do the same for a chance at stardom in an online commercial.

“For contestants on the hottest TV show in America, the stakes are high. They’re sharing their talent and giving their best, so I owe it to them to focus on their performance, not my allergies,” said DioGuardi. “That’s why I choose CLARITIN to relieve my worst allergies without making me drowsy. If I miss a detail, someone could miss their big chance.”

DioGuardi is one of millions of Americans who rely on non-drowsy CLARITIN to manage their indoor and outdoor allergy symptoms, and the brand wants to hear from others.

From now until April 20, 2010, allergy sufferers can go to www.LivingClear.com to submit a video showing what they’ve been enabled to do — from the everyday to the extraordinary — because CLARITIN relieves their worst allergy symptoms without drowsiness. Five finalists will win $1,000, a one-year supply of CLARITIN products and have their video featured on the Living Clear Web site. The grand prize winner will receive $10,000 and the chance to star in an online CLARITIN commercial to be debuted later this year. (more…)